Kapurniotu Aphrodite, Schmauder Anke, Tenidis Konstantinos
Physiological-chemical Institute, University of Tübingen, D-72076 Tübingen, Germany.
J Mol Biol. 2002 Jan 18;315(3):339-50. doi: 10.1006/jmbi.2001.5244.
Pancreatic amyloid is formed by the aggregation of the 37-residue islet amyloid polypeptide (IAPP) in type II diabetes patients and is cytotoxic. Pancreatic amyloid deposits are found in more than 95 % of type II diabetes patients and their formation is strongly associated with disease progression. IAPP amyloid forms via a conformational transition of soluble IAPP into aggregated beta-sheets. We recently identified IAPP(22-27) (NFGAIL) as a minimum length sequence sufficient to self-associate into beta-sheet-containing amyloid fibrils. Here, we have used the NFGAIL model of the IAPP amyloid core as a structural template to design non-amyloidogenic derivatives of amyloidogenic sequences of IAPP that are able to interact with the native sequences and inhibit amyloid formation. The design of the derivatives was based on a simple, structure-based minimalistic and selective N-methylation approach. Accordingly, a minimum number of two amide bonds on the same side of the beta-strand of the amyloid core was N-methylated. This was expected to eliminate the two intermolecular backbone NH to CO hydrogen bonds which are critical for the extension of the beta-sheet dimers into multimers and amyloid. Other beta-strand "contact sides" remained intact allowing for the derivatives to interact with the native sequences. Double N-methylated derivatives of amyloidogenic and cytotoxic partial IAPP sequences generated included F(N-Me)GA(N-Me)IL, NF(N-Me)GA(N-Me)IL, SNNF(N-Me)GA(N-Me)IL, and SNNF(N-Me)GA(N-Me)ILSS and were found to be devoid of beta-sheet structure, amyloidogenicity and cytotoxicity according to Fourier transform-infrared spectroscopy (FT-IR), Congo red (CR) staining, electron microscopy (EM), and cell viability tests. The derivatives were able to interact with the native sequences and inhibit amyloid formation as shown by circular dichroism spectroscopy (CD), FT-IR and EM. Moreover, SNNF(N-Me)GA(N-Me)ILSS inhibited cytotoxicity of SNNFGAILSS and is thus the first reported inhibitor of IAPP amyloid formation and cytotoxicity. Our results demonstrate the validity of the design approach for IAPP and suggest that it may find application in understanding the structural features of amyloid formation and in the development of inhibitors of amyloid formation and cytotoxicity of other amyloidogenic polypeptides as well.
在II型糖尿病患者中,胰岛淀粉样多肽(IAPP)由37个氨基酸残基聚集形成胰腺淀粉样蛋白,具有细胞毒性。超过95%的II型糖尿病患者存在胰腺淀粉样蛋白沉积,其形成与疾病进展密切相关。IAPP淀粉样蛋白通过可溶性IAPP的构象转变形成聚集的β-折叠。我们最近鉴定出IAPP(22 - 27)(NFGAIL)是足以自组装成含β-折叠淀粉样纤维的最短序列。在此,我们以IAPP淀粉样核心的NFGAIL模型为结构模板,设计IAPP淀粉样生成序列的非淀粉样生成衍生物,这些衍生物能够与天然序列相互作用并抑制淀粉样形成。衍生物的设计基于一种简单的、基于结构的简约且选择性的N-甲基化方法。因此,淀粉样核心β-链同一侧最少数量的两个酰胺键被N-甲基化。预计这将消除两个分子间主链NH到CO的氢键,这两个氢键对于β-折叠二聚体扩展为多聚体和淀粉样蛋白至关重要。其他β-链“接触侧”保持完整,使衍生物能够与天然序列相互作用。生成的淀粉样生成和细胞毒性部分IAPP序列的双N-甲基化衍生物包括F(N-Me)GA(N-Me)IL、NF(N-Me)GA(N-Me)IL、SNNF(N-Me)GA(N-Me)IL和SNNF(N-Me)GA(N-Me)ILSS;根据傅里叶变换红外光谱(FT-IR)、刚果红(CR)染色、电子显微镜(EM)和细胞活力测试发现,这些衍生物没有β-折叠结构、淀粉样生成性和细胞毒性。如圆二色光谱(CD)、FT-IR和EM所示,这些衍生物能够与天然序列相互作用并抑制淀粉样形成。此外,SNNF(N-Me)GA(N-Me)ILSS抑制了SNNFGAILSS的细胞毒性,因此是首个报道的IAPP淀粉样形成和细胞毒性抑制剂。我们的结果证明了IAPP设计方法的有效性,并表明它可能在理解淀粉样形成的结构特征以及开发其他淀粉样生成多肽的淀粉样形成和细胞毒性抑制剂方面找到应用。